about us

OUR BOARD

Mats Johnson

Chairman of the board

Mats has almost 40 years of experience from the life science area in biotech supply, drug discovery and genetic modifications of plants mainly in different business positions but also from R&D with the companies Pharmacia Biotech, Amersham Biosciences, SweTree Technologies and Bio-Works Technologies. In the last two companies Mats was CEO, all-in-all, for almost 15 years. SweTree was brought to profitability and Bio-Works was built to an IPO, with relevant industrial structures and global market access. Mats has during the last 15 years been instrumental in finding financing of almost 500 MSEK for SweTree, its spin-outs and Bio-Works.

 

Erik Walldén

Director

Mr. Erik Walldén has a record of achievement from over 30 years leadership in the international Life Science industry. He has led the global launching of several new technologies, established and restructured companies, successfully closed private placements and IPOs. He is currently acting as private investor, consultant and advisor through his own company Erik Wallden AB. Mr. Wallden has been the CEO for the Swedish company Gyros AB (2009-2013. Before that the CEO of the Swedish biotech company Affibody Holding AB (2006-2009), Biacore International AB (2004-2006), and before that the CEO of Pyrosequencing AB (1998-2004). He has been active in establishing and part of the executive management of companies such as the US based PerSeptive Biosystems Inc., Pharmacia Biosensor AB and Pharmacia Biotech AB. Mr. Walldén is the Chairman of the Board of Erik Wallden AB and member of the boards of Beactica AB and Symcel AB.

 

Kristina Köhler

Director

Dr. Köhler is a senior leader with extensive experience in biopharmaceutical development and industrialization from Sobi and its predecessors. Focus areas are upstream and downstream development including scale-up and manufacturing. She has also been involved in several Vinnova funded competence centra and projects. She holds a MSc in Chemical Engineering and a PhD in Biotechnology from Royal Institute of Technology, Stockholm, Sweden.

 

Pär Nordström

Director

Pär operates several wholly-owned businesses within farming, fabrics, household goods, toys and gift items as well as sales and management of real estate activities and venture capital investments. He is a experienced investor and was the first non-founder shareholder in the company.

Kristofer Eriksson

Deputy
Kristofer has a PhD in organic chemistry from Stockholm University and is co-inventor of MAGic core technology. Has developed the manufacturing process of the magnetic beads and magnetic separators as well as the downstream applications.

 

Mats Ekholm

Deputy

Mats has a background as an engineer at Scanditronix and GEMS Pet systems, production, engineering, design of particle accelerators (cyclotrons) used mainly for PET cancer diagnostics. Currently he works as CEO at Uppsala Cementgjuteri, concrete products and materials industry, real estate development, facility management and venture capital investments.

 

 

MANAGEMENT

Peter Karlberg

CEO
Peter holds a BSc in molecular biology from Uppsala University. He has more than 20 years of experience from international commercialising of expanding enterprises as well as launching new product lines for larger life science companies. 

email: peter@magicbioprocessing.com

mobile: +46 763 290 814

Kristofer Eriksson

CTO
Kristofer has a PhD in organic chemistry from Stockholm University and is co-inventor of MAGic core technology. Has developed the manufacturing process of the magnetic beads and magnetic separators as well as the downstream applications.

email: kristofer@magicbioprocessing.com

mobile: +46 704 419 330

Nils Brechmann

Product and Marketing Manager
Nils holds a PhD in Industrial Biotechnology from the Royal Institute of Technology (KTH) in Stockholm, Sweden. He has been deeply involved and is a co-inventor in the development of the process application.

email: nils@magicbioprocessing.com

mobile: +46 708 441 453

Per-Olov Eriksson

Senior Advisor
Per-Olov has extensive industrial experience spanning nearly three decades to design, construct and validate critical bioprocesses at international biopharma companies. Co-inventor of MAGic Process. Currently work as an independent consultant for several biotech companies in Sweden.

 

Maria Brunn

CFO
Maria has a Ba in Economics from Stockholm University and currently work as a senior financial consultant.

 

EUR
USD
EUR
USD